Order Article Reprints

Delage JA, Faivre-Chauvet A, Barbet J, Fierle JK, Schaefer N, Coukos G, Viertl D, Dunn SM, Gnesin S, Prior JO. Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [¹⁷⁷Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model. Pharmaceutics. 2021; 13(1):96. https://doi.org/10.3390/pharmaceutics13010096

Delage, Judith Anna, Alain Faivre-Chauvet, Jacques Barbet, Julie Katrin Fierle, Niklaus Schaefer, George Coukos, David Viertl, Steven Mark Dunn, Silvano Gnesin, and John O. Prior. 2021. "Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [¹⁷⁷Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model" Pharmaceutics 13, no. 1: 96. https://doi.org/10.3390/pharmaceutics13010096

Delage, J. A., Faivre-Chauvet, A., Barbet, J., Fierle, J. K., Schaefer, N., Coukos, G., Viertl, D., Dunn, S. M., Gnesin, S., & Prior, J. O. (2021). Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [¹⁷⁷Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model. Pharmaceutics, 13(1), 96. https://doi.org/10.3390/pharmaceutics13010096